A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Clinical trial NCT07073950 · RECRUITING
Trial details
- NCT number
- NCT07073950
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-24
- Primary completion
- 2027-05-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.